Molecule Details
| InChIKey | PMFBLJXNSAHZSG-BMRADRMJSA-N |
|---|---|
| Compound Name | N-(1-Benzyl-2-carbamoyl-2-oxo-ethyl)-2-(2-naphthalen-2-yl-vinyl)-benzamide |
| Canonical SMILES | NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1ccccc1/C=C/c1ccc2ccccc2c1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.92 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P07384 | CAPN1 | Homo sapiens | Human | PF01067 PF13833 PF00648 | 8.2 | Ki | ChEMBL |
| P18505 | GABRB1 | Homo sapiens | Human | PF02931 PF02932 | 8.2 | pIC50 | TTD_MultiTarget |
| P07858 | CTSB | Homo sapiens | Human | PF00112 PF08127 | 7.0 | Ki | ChEMBL |
| Q8I6Z5 | PMV | Plasmodium falciparum (isolate 3D7) | Pathogen | PF00026 PF14543 | 8.2 | pIC50 | TTD_MultiTarget |